박성진 (Massachusetts General Hospital and Harvard Medical School)님 | 한빛사연구자 > 한빛사

Massachusetts General Hospital and Harvard Medical School

최종업데이트 2025.12.17.

Charge-based Supramolecular Peptide Nanocomplexes for Oral Delivery via Transporter-driven Endocytosis
- Biomaterials, Available online 12 December 2025 | https://doi.org/10.1016/j.biomaterials.2025.123903
- 2025-12
- 의약학
- 한빛사논문
An in situ immunogenicity-amplifying payload delivery system for immunotherapy of Kirsten rat sarcoma viral oncogene homolog–mutant cancer
- J. Control. Release, Available online 1 November 2025, 114380 | https://doi.org/10.1016/j.jconrel.2025.114380
- 2025-11
- 바이오·의료융합
- 한빛사논문
Cell-Penetrating Peptide Like Anti-Programmed Cell Death-Ligand 1 Peptide Conjugate-Based Self-Assembled Nanoparticles for Immunogenic Photodynamic Therapy
- ACS Nano, Jan 06 2025, | https://doi.org/10.1021/acsnano.4c16128
- 2025-01
- 바이오·의료융합
- 한빛사논문
Stimulating macropinocytosis of peptide-drug conjugates through DNA-dependent protein kinase inhibition for treating KRAS-mutant cancer
- J. Control. Release, Jun 20 2024, 372 S0168-3659(24)00376-6 | https://doi.org/10.1016/j.jconrel.2024.06.028
- 2024-06
- 생명과학
- 한빛사논문
Immune modulation of the liver metastatic colorectal cancer microenvironment via the oral CAPOX-mediated cGAS-STING pathway
- Biomaterials, May 25 2024, 310 S0142-9612(24)00159-5 | https://doi.org/10.1016/j.biomaterials.2024.122625
- 2024-05
- 생명과학
- 한빛사논문

연구자 ID

저자논문